Providing hope in terminal cancer: When is it appropriate and when is it not?

Annals of the Academy of Medicine Singapore

Volumn 40, Issue 1, 2011, Pages 50-55

  Toh, Han Chong ^a  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

Communicating prognosis; Dying well; Therapeutic nihilism

Indexed keywords

CAPECITABINE; DOCETAXEL; ERLOTINIB; FLUOROURACIL; GEMCITABINE; IRINOTECAN; OXALIPLATIN;

ARTICLE; CANCER PATIENT; CANCER SURVIVAL; DISEASE COURSE; DOCTOR PATIENT RELATION; DYING; EMOTION; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEALTH INSURANCE; HOPE; HUMAN; HUMOR; INTERPERSONAL COMMUNICATION; MEDICAL SPECIALIST; NEOPLASM; ONCOLOGY; OUTCOME ASSESSMENT; PANCREAS CANCER; PANCREAS TUMOR; PROGRESSION FREE SURVIVAL; PSYCHOSOCIAL CARE; QUALITY OF LIFE; SPIRITUAL CARE; TERMINAL DISEASE;

EID: 79951829942     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Groopman J. The Anatomy of Hope: How people prevail in the face of illness. New York: Random House, 2003.
2. Meropol NJ, Schulman KA. Cost of cancer care: issues and implications. J Clin Oncol 2007;25:180-6.
3. Saltz LB. Progress in cancer care: the hope, the hype, and the gap between reality and perception. J Clin Oncol 2008;26:5020-1.
4. Kim P. Cost of Cancer Care: the patient perspective. J Clin Oncol 2007;25:228-32.
5. Kolata G. Hope in the lab: a special report -a cautious awe greets drugs that eradicate tumors in mice. The New York Times, 3 May 1998.
6. Hagerty RG, Butow PN, Ellis PM, Lobb EA, Pendlebury SC, Leighl N, et al. Communicating with realism and hope: incurable cancer patients' views on the disclosure of prognosis. J Clin Oncol 2005;23:1278-88.
7. Oken D. What to tell cancer patients. A study of medical attitudes. JAMA 1961;175:1120-8.
8. Oken D. The doctor's job - an update. Psychosom Med 1978;40:449-61.
9. Mack JW, Wolfe J, Cook EF, Grier HE, Cleary PD, Weeks JC. Hope and prognostic disclosure. J Clin Oncol 2007;25:5636-42.
10. Baile WF, Buckman R, Lenzi R, Glober G, Beale EA, Kudelka AP. SPIKES - A six-step protocol for delivering bad news: application to the patient with cancer. Oncologist 2000;5:302-11.
11. Annas GJ. Informed consent, cancer, and truth in prognosis. N Engl J Med 1994;330:223-5.
12. Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997;15:2403-13.
13. Cunningham D, Chau I, Stocken DD, Valle JW, Smith D, Steward W, et al. Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer. J Clin Oncol 2009;27:5513-8.
14. Moore MJ, Goldstein D, Hamm J, Figer A, Hecht JR, Gallinger S, et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 2007;25:1960-6.
15. Miksad RA, Schnipper L, Goldstein M. Does a statistically significant survival benefit of erlotinib plus gemcitabine for advanced pancreatic cancer translate into clinical significance and value? J Clin Oncol 2007;25:4506-7.
16. Bruckner H, Chawla SP, Chua CS, Quoin DV, Fernandez L, Marylou A, et al. Phase I and II studies of intravenous Rexin-G as monotherapy for stage IVb gemcitabine-resistant pancreatic cancer. J Clin Oncol 2010;28:7s (suppl; abstr 4149).
17. Gould SJ. The median isn't the message. Ceylon Med J 2004;49:139-40
18. Gawande A. Letting Go. What should medicine do when it can't save your life? The New Yorker, August, 2010.
19. Schilsky RL. Personalized medicine in oncology: the future is now. Nat Rev Drug Discov 2010;9:363-6.
20. Penson RT, Gu F, Harris S, Thiel MM, Lawton N, Fuller AF Jr, et al. Hope. Oncologist 2007;12:1105-13.
21. Sherman KA, Heard G, Cavanagh KL. Psychological effects and mediators of a group multi-component program for breast cancer survivors. J Behav Med 2010. Epub 26 May 2010.
22. Morey MC, Snyder DC, Sloane R, Cohen HJ, Peterson B, Hartman TJ, et al. Effects of home-based diet and exercise on functional outcomes among older, overweight long-term cancer survivors: RENEW: a randomized controlled trial. JAMA 2009;301:1883-91.
23. Balboni TA, Paulk ME, Balboni MJ, Phelps AC, Loggers ET, Wright AA, et al. Provision of spiritual care to patients with advanced cancer: associations with medical care and quality of life near death. J Clin Oncol 2010;28:445-52.
24. Chin JJ. Medical professionalism in the internet age. Ann Acad Med Singapore 2010;39:345-3.
25. Taylor C, Graham J, Potts HW, Richards MA, Ramirez AJ. Changes in mental health of UK hospital consultants since the mid-1990s. Lancet 2005;366:742-4.
26. Daneault S, Dion D, Sicotte C, Yelle L, Mongeau S, Lussier V, et al. Hope and noncurative chemotherapies: which affects the other? J Clin Oncol 2010;28:2310-3.
27. Clark D. Between hope and acceptance: the medicalisation of dying. BMJ 2002;905:905-7.
28. Grant L, Murray SA, Sheikh A. Spiritual dimensions of dying in pluralist societies. BMJ 2010;341:c4859.